why choose us

First received: May 01, 2023

Clinical Trial: Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hepatorenal Syndrome

Study Type: INTERVENTIONAL


Official Title: A Single-blind, Phase 2, Multi-center, Randomized Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatore

Brief Summary: This study aims to evaluate the safety, tolerability and efficacy of R2R01 combined with terlipressin as compared to terlipressin alone in the treatment of patients with HRS-AKI

Read more